OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Oculis Holding AG
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026
$7.32+0.03 (+0.41%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Jun 30, 2026
Oculis reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Oculis's annual report. Trading prices and yields need FINRA TRACE data.